Is the use of low molecular weight heparin a rational choice during pregnancy in patients with a mechanical heart valve: a report of three cases [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 2019; 47(1): 63-68 | DOI: 10.5543/tkda.2018.83364

Is the use of low molecular weight heparin a rational choice during pregnancy in patients with a mechanical heart valve: a report of three cases

Ahmet Güner, Emrah Bayam, Semih Kalkan, Sabahattin Gündüz, Mehmet Özkan
Department of Cardiology, Kartal Koşuyolu High Speciality Training and Research Hospital, İstanbul, Turkey

Pregnancy is associated with an increased risk of valve thrombosis in patients with a mechanical prosthetic heart valve. The administration of low molecular weight heparin (LMWH) with regular anti-factor Xa assessment is a recommended treatment modality for these patients. Presently described are 3 cases of therapy with LMWH during pregnancy. Despite frequent anti-factor Xa monitoring, not surprisingly, all of them developed prosthetic valve thrombosis.

Keywords: Low molecular weight heparin, mechanical heart valve, prosthetic valve thrombosis.















How to cite this article
Ahmet Güner, Emrah Bayam, Semih Kalkan, Sabahattin Gündüz, Mehmet Özkan. Is the use of low molecular weight heparin a rational choice during pregnancy in patients with a mechanical heart valve: a report of three cases. Turk Kardiyol Dern Ars. 2019; 47(1): 63-68

Corresponding Author: Ahmet Güner, Türkiye
© Copyright 2019 Archives of the Turkish Society of Cardiology
LookUs & Online Makale